written on 24.04.2014

Market Insight: Takeda Facing $9 Billion in Damages in Relation to Actos Cancer Risk


A Louisiana jury wrote history on April 07, 2013, when it ordered a total of $9 billion in punitive and $1.5 million in compensatory damages to be paid to a New York couple over claims that Takeda concealed cancer risks associated with its blockbuster diabetes drug Actos (pioglitazone). This ruling will be welcomed by thousands […]